Lantheus Holdings Inc (NASDAQ:LNTH) Director Brian A. Markison sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, June 19th. The shares were sold at an average price of $27.40, for a total value of $137,000.00. Following the completion of the transaction, the director now owns 42,467 shares in the company, valued at approximately $1,163,595.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Lantheus stock opened at $27.85 on Monday. The stock has a market capitalization of $1.08 billion, a P/E ratio of 29.63, a PEG ratio of 2.09 and a beta of 1.46. Lantheus Holdings Inc has a 12-month low of $12.59 and a 12-month high of $28.48. The company has a current ratio of 4.57, a quick ratio of 3.82 and a debt-to-equity ratio of 3.16.

Lantheus (NASDAQ:LNTH) last posted its quarterly earnings results on Tuesday, April 30th. The medical equipment provider reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.03. The business had revenue of $86.51 million for the quarter, compared to analysts’ expectations of $86.80 million. Lantheus had a return on equity of 59.57% and a net margin of 12.17%. As a group, equities analysts predict that Lantheus Holdings Inc will post 1.11 earnings per share for the current fiscal year.

Institutional investors have recently bought and sold shares of the stock. PNC Financial Services Group Inc. boosted its holdings in Lantheus by 51.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 1,694 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 575 shares during the last quarter. Advisor Group Inc. boosted its holdings in Lantheus by 1,837.2% in the fourth quarter. Advisor Group Inc. now owns 4,378 shares of the medical equipment provider’s stock valued at $69,000 after acquiring an additional 4,152 shares during the last quarter. First Quadrant L P CA bought a new position in Lantheus during the first quarter worth about $95,000. Anderson Fisher LLC bought a new position in Lantheus during the first quarter worth about $112,000. Finally, Meeder Asset Management Inc. boosted its holdings in Lantheus by 212.8% during the first quarter. Meeder Asset Management Inc. now owns 4,757 shares of the medical equipment provider’s stock worth $115,000 after buying an additional 3,236 shares during the last quarter. Institutional investors and hedge funds own 92.55% of the company’s stock.

LNTH has been the topic of several recent research reports. TheStreet upgraded Lantheus from a “c+” rating to a “b” rating in a report on Monday, March 4th. BidaskClub cut Lantheus from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 11th. Finally, Zacks Investment Research upgraded Lantheus from a “hold” rating to a “buy” rating and set a $27.00 price target on the stock in a report on Thursday, April 4th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $23.33.

Lantheus Company Profile

Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, a microbubble contrast agent used in ultrasound exams of the heart; and TechneLite, a technetium generator that provides the nuclear material used in nuclear medicine procedures.

Read More: Why is cost of goods sold important?

Insider Buying and Selling by Quarter for Lantheus (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.